New data from University of Southern California

July 15, 2015 via University of Southern California

New study demonstrates LINX® safety and efficacy rivals laparoscopic Nissen fundoplication. Study authors conclude LINX is as effective as Nissen in controlling reflux, with fewer side effects.

Torax Medical, Inc. announced today the release of new data from the University of Southern California's Keck Medicine, a leading institution in the diagnosis and treatment of gastro-esophageal reflux disease (GERD). The retrospective study, led by Dr. John C. Lipham, compared the LINX® Reflux Management System (LINX) to the standard of care of Laparoscopic Nissen Fundoplication (LNF) in similar patient populations.

Download the PDF below for the complete PR release.

Download PDF

View Indications, Safety and Warnings

Would you like Torax Medical to send information on LINX to the doctor currently treating your reflux disease?

  • Lorem can't be blank
  • Lorem can't be blank

The information provided on this website is not medical advice and is intended for educational purposes only. Talk to a doctor if you have concerns about your health. Call 911 in the event of a medical emergency. Please do not submit medical information to this website or request treatment advice. For more information about the benefits and risks of LINX please click here.

Message Sent!

Thank you for your submission.
We will be in contact with your doctor.